Tag: liver cirrhosis treatment market

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Liver Cirrhosis Market Expected To Expand Between 2025 And 2029?

The liver cirrhosis market has experienced substantial growth recently. It is projected to expand from $1.86 billion in 2024 to $1.99 billion in 2025, at a compound annual growth rate (CAGR) of 7.0%. This historical growth can be attributed to the increasing incidence of liver diseases, high levels of alcohol consumption, an aging global population, augmented healthcare expenditure, and the rise in government-led initiatives.

The liver cirrhosis market is anticipated to experience robust expansion in the upcoming years. Its valuation is projected to reach $2.68 billion by 2029, achieving a compound annual growth rate (CAGR) of 7.7%. This projected increase throughout the forecast period stems from factors such as the increasing prevalence of hepatitis infections, a surge in economic growth, expanding urbanization, evolving lifestyle patterns, and the rise of medical tourism. Key developments expected during this period encompass progress in diagnostic instrumentation, breakthroughs in technology, strategic alliances and joint ventures, the incorporation of artificial intelligence, and the adoption of holistic treatment approaches.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22040&type=smp

What Are The Key Drivers Of Growth In The Liver Cirrhosis Market?

The anticipated increase in alcohol consumption is expected to propel the growth of the liver cirrhosis market going forward. Alcohol consumption refers to the intake of alcoholic beverages, typically measured by quantity and frequency. People are increasingly consuming alcohol because it helps them unwind from daily stress, fosters social connections in gatherings, and enhances moments of relaxation, while also benefiting from widespread media promotion and greater accessibility in various settings. Liver cirrhosis treatment for patients with excessive alcohol consumption focuses on managing liver damage through abstinence, medications, and supportive care, concurrently addressing alcohol dependence with counseling and rehabilitation. For instance, in March 2023, according to the National Drugs Library, an Ireland-based data collection organization, in 2022, the average alcohol consumption for individuals over 15 years old rose to 10.2 liters of pure alcohol per capita, reflecting a 7.6% increase from 2021. Therefore, increasing alcohol consumption drives the liver cirrhosis market.

What Are The Major Segment Categories Driving The Liver Cirrhosis Market Growth?

The liver cirrhosismarket covered in this report is segmented –

1) By Type: Alcoholic Cirrhosis; Atrophic Cirrhosis; Biliary Cirrhosis; Cardiac Cirrhosis; Cryptogenic Cirrhosis

2) By Treatment: Antibiotics; Immunosuppressants; Other Treatments

3) By End Users: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Academic And Research Institutes; Other End Users

Subsegments:

1) By Alcoholic Cirrhosis: Compensated Alcoholic Cirrhosis; Decompensated Alcoholic Cirrhosis; Alcoholic Steatohepatitis (ASH)-Associated Cirrhosis

2) By Atrophic Cirrhosis: Post-necrotic Atrophic Cirrhosis; Macronodular Atrophic Cirrhosis; Micronodular Atrophic Cirrhosis

3) By Biliary Cirrhosis: Primary Biliary Cirrhosis (PBC); Secondary Biliary Cirrhosis; Autoimmune Biliary Cirrhosis

4) By Cardiac Cirrhosis: Right Heart Failure-Induced Cirrhosis; Chronic Passive Congestion Cirrhosis; Ischemic Hepatitis Cirrhosis

5) By Cryptogenic Cirrhosis: Non-Alcoholic Steatohepatitis (NASH)-Associated Cirrhosis; Idiopathic Cirrhosis; Metabolic Syndrome-Associated Cirrhosis

How Are Emerging Market Trends Shaping The Liver Cirrhosis Industry Landscape?

Companies operating in the liver cirrhosis market are increasingly concentrating on advancements in treatment options, such as the development of active implantable medical devices, with the aim of improving patient outcomes and expanding therapeutic possibilities. Active implantable medical devices are electronically powered implants specifically designed to monitor, support, or improve organ function within the body. For example, in December 2024, Sequana Medical NV, a Belgium-based medical device company, obtained U.S. FDA approval for its alfapump system, which is the first active implantable medical device in the U.S. for managing recurrent or refractory ascites caused by liver cirrhosis. This innovative technology offers a continuous, automated solution for fluid management by moving excess abdominal fluid to the bladder, considerably lessening reliance on invasive therapeutic paracentesis. The alfapump represents a significant advancement in enhancing patient outcomes and elevating quality of life, addressing a market of approximately 70,000 patients in the United States.

Who Are The Primary Competitors In The Global Liver Cirrhosis Market?

Major companies operating in the liver cirrhosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Viatris Inc., Grifols Therapeutics LLC, Shionogi Inc., Galectin Therapeutics Inc., NGM Biopharmaceuticals Inc., Madrigal Pharmaceuticals Inc., Akero Therapeutics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/liver-cirrhosis-global-market-report

Which Regional Markets Are Contributing Most To The Liver Cirrhosis Industry Expansion?

North America was the largest region in the liver cirrhosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cirrhosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Liver Cirrhosis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=22040&type=smp

Browse Through More Reports Similar to the Global Liver Cirrhosis Market 2025, By The Business Research Company

Liver Diseases Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Liver Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Human Liver Model Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Liver Cirrhosis Market Through 2034?

The market size for liver cirrhosis has seen robust growth in the past few years. There would be an upsurge from $1.86 billion in 2024 to $1.99 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.0%. The notable growth observed in the past has been linked to proliferating cases of liver ailments, elevated levels of alcohol intake, a growing older population, augmented expenditure in healthcare, and ramped up government initiatives.

Anticipations are high for substantial expansion of the liver cirrhosis market in the imminent years. The market is projected to amass a worth of$2.68 billion by 2029, escalating at a compounded annual growth rate (CAGR) of 7.7%. The predicted upturn within this period can be tied to an increased prevalence of hepatitis infections, burgeoning economic development, urbanization increment, shifts in lifestyle patterns, and the rise of the medical tourism sector. Future trends expected to impact this period encompass advancements in diagnostic appliances, technological breakthroughs, alliances and partnerships, incorporation of artificial intelligence, and the integration of all-encompassing treatments.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22040&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Liver Cirrhosis Market?

The liver cirrhosis market is projected to grow fueled by a spike in alcohol consumption. This refers to the quantity and routine of alcoholic beverage intake. The primary reasons for this upturn include people’s need to de-stress, the ability of alcohol to facilitate social interactions, and its role in amping relaxation moments. This is further incentivized by its widespread advertisement and availability in different places. Liver cirrhosis treatment for heavy drinkers centers on limiting liver injury through sobriety, medication, and supportive therapy. It also takes care of alcohol addiction through psychological counseling and rehab. For instance, as per data from the National Drugs Library of Ireland, there was a 7.6% uptick in the average alcohol consumption per capita, reaching 10.2 liters of pure alcohol for individuals aged 15 and above in 2022. Hence, the rise in alcohol consumption propels the liver cirrhosis market.

Which Key Market Segments Comprise the Liver Cirrhosis Market and Drive Its Revenue Growth?

The liver cirrhosismarket covered in this report is segmented –

1) By Type: Alcoholic Cirrhosis; Atrophic Cirrhosis; Biliary Cirrhosis; Cardiac Cirrhosis; Cryptogenic Cirrhosis

2) By Treatment: Antibiotics; Immunosuppressants; Other Treatments

3) By End Users: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Academic And Research Institutes; Other End Users

Subsegments:

1) By Alcoholic Cirrhosis: Compensated Alcoholic Cirrhosis; Decompensated Alcoholic Cirrhosis; Alcoholic Steatohepatitis (ASH)-Associated Cirrhosis

2) By Atrophic Cirrhosis: Post-necrotic Atrophic Cirrhosis; Macronodular Atrophic Cirrhosis; Micronodular Atrophic Cirrhosis

3) By Biliary Cirrhosis: Primary Biliary Cirrhosis (PBC); Secondary Biliary Cirrhosis; Autoimmune Biliary Cirrhosis

4) By Cardiac Cirrhosis: Right Heart Failure-Induced Cirrhosis; Chronic Passive Congestion Cirrhosis; Ischemic Hepatitis Cirrhosis

5) By Cryptogenic Cirrhosis: Non-Alcoholic Steatohepatitis (NASH)-Associated Cirrhosis; Idiopathic Cirrhosis; Metabolic Syndrome-Associated Cirrhosis

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=22040&type=smp

Which Areas Are Leading Regions in the Liver Cirrhosis Market Expansion Across the Globe?

North America was the largest region in the liver cirrhosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cirrhosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theLiver Cirrhosis Market Over the Coming Years?

Primary businesses engaged in the liver cirrhosis market are directing their focus towards the evolution of more sophisticated options for treatment, with a primary focus on the inception of technology in active implantable medical devices. These are electronically driven implants which are engineered to support, monitor or enhance the functioning of human organs. For instance, in December 2024, Sequana Medical NV, a medical device company based in Belgium, was granted approval by the U.S. FDA for its alfapump system, hailed as the first active implantable medical device for efficient management of recurring or stubborn ascites triggered by liver cirrhosis within the U.S. This impressive invention provides an automated, continual solution for fluid regulation by shifting excess fluid in the abdomen to the bladder, drastically lessening reliance on invasive therapeutic paracentesis procedures. The alfapump showcases significant progress in patient outcomes enhancement, as well as the enrichment of life quality, targeting a potential market of around 70,000 patients on U.S. soil.

View the full report here:

https://www.thebusinessresearchcompany.com/report/liver-cirrhosis-global-market-report

How Is the Liver Cirrhosis Market Conceptually Defined?

Liver cirrhosis is a progressive disease in which healthy liver tissue is gradually replaced by scar tissue, impairing the liver’s ability to function properly. This condition results from prolonged liver damage caused by factors such as chronic alcohol consumption, viral hepatitis, or fatty liver disease.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22040

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Liver Cirrhosis Market from 2024 to 2025?

The market for liver cirrhosis has experienced swift expansion in the past few years. The forecast entails a surge from $1.86 billion in 2024 to $2.01 billion in 2025, representing a compound annual growth rate (CAGR) of 8.3%. The noteworthy expansion during the historic era can be ascribed to the rising incidence of liver conditions, high levels of alcohol intake, an older demographic, enhanced healthcare spending, and escalating government initiatives.

What Is the Projected Market Size of the Liver Cirrhosis Market?

In the coming years, the market size for liver cirrhosis is predicted to witness a surge, ballooning to $2.74 billion by 2029, with a compound annual growth rate (CAGR) of 8.0%. The growth during this projected period can be credited to factors such as an increase in hepatitis infections, economic development, urbanization, shifts in lifestyle, and a rise in medical tourism. Significant trends during this forecasted period encompass progress in diagnostic tools, technological advancements, collaborations and alliances, the incorporation of artificial intelligence, and the application of holistic therapies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22040&type=smp

Who are the Major Competitors in the Liver Cirrhosis Market Outlook?

Major companies operating in the liver cirrhosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Viatris Inc., Grifols Therapeutics LLC, Shionogi Inc., Galectin Therapeutics Inc., NGM Biopharmaceuticals Inc., Madrigal Pharmaceuticals Inc., Akero Therapeutics Inc.

What Is Fueling Growth in the Liver Cirrhosis Market?

The surge in the intake of alcoholic beverages is predicted to drive the evolution of the liver cirrhosis market in the future. The term ‘alcohol consumption’ refers to the amount and frequency of alcohol intake. The rising popularity of alcohol can be attributed to its perceived stress-relieving properties, its role in social bonding, its media promotion, and increased accessibility in various locales. The primary treatment strategy for liver cirrhosis in patients who consume excessive amounts of alcohol revolves around managing liver damage through avoidance of alcohol, medications, and supplementary care, coupled with addressing alcohol addiction through therapy and rehabilitation. For instance, data from the National Drugs Library based in Ireland, as of March 2023, indicates that the per capita alcohol consumption for those aged 15 and above increased to 10.2 liters of pure alcohol in 2022, marking a 7.6% rise compared to 2021. Consequently, it’s clear that the escalation in alcohol consumption fuels the growth of the liver cirrhosis market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=22040&type=smp

Which Liver Cirrhosis Market Segments Are Growing the Fastest?

The liver cirrhosis market covered in this report is segmented –

1) By Type: Alcoholic Cirrhosis, Atrophic Cirrhosis, Biliary Cirrhosis, Cardiac Cirrhosis, Cryptogenic Cirrhosis

2) By Treatment: Antibiotics, Immunosuppressants, Other Treatments

3) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes, Other End Users

Subsegmentss:

1) By Alcoholic Cirrhosis: Compensated Alcoholic Cirrhosis, Decompensated Alcoholic Cirrhosis, Alcoholic Steatohepatitis (ASH)-Associated Cirrhosis

2) By Atrophic Cirrhosis: Post-necrotic Atrophic Cirrhosis, Macronodular Atrophic Cirrhosis, Micronodular Atrophic Cirrhosis

3) By Biliary Cirrhosis: Primary Biliary Cirrhosis (PBC), Secondary Biliary Cirrhosis, Autoimmune Biliary Cirrhosis

4) By Cardiac Cirrhosis: Right Heart Failure-Induced Cirrhosis, Chronic Passive Congestion Cirrhosis, Ischemic Hepatitis Cirrhosis

5) By Cryptogenic Cirrhosis: Non-Alcoholic Steatohepatitis (NASH)-Associated Cirrhosis, Idiopathic Cirrhosis, Metabolic Syndrome-Associated Cirrhosis

Which Industry Trends Are Shaping the Future of the Liver Cirrhosis Market?

Key players in the liver cirrhosis market are shifting their focus towards technological advancements in treatment strategies, such as designing and developing active implantable medical devices, to enhance patient recovery and widen therapeutic opportunities. These electronically powered implanted devices have been engineered to track, support, or ameliorate organ functionality within the body. For example, in December 2024, Sequana Medical NV, a medical device firm based in Belgium, was granted approval by the US FDA for its alfapump system – the primary active implantable medical device in the US for treating recurring or resistant ascites resulting from liver cirrhosis. This cutting-edge technology offers an automated, continuous solution for managing fluids by transferring the excess fluid in the abdomen to the bladder, thereby significantly diminishing the reliance on invasive therapeutic paracentesis. The alfapump has majorly attributing an uplift in patient recovery rates and bettering their quality of life, with an approximate target market of 70,000 patients within the United States.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/liver-cirrhosis-global-market-report

Which Countries Are Leading the Liver Cirrhosis Market?

North America was the largest region in the liver cirrhosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cirrhosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22040

This Report Delivers Insight On:

1. How big is the liver cirrhosis market, and how is it changing globally?

2. Who are the major companies in the liver cirrhosis market, and how are they performing?

3. What are the key opportunities and risks in the liver cirrhosis market right now?

4. Which products or customer segments are growing the most in the liver cirrhosis market?

5. What factors are helping or slowing down the growth of the liver cirrhosis market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the liver cirrhosis industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Liver Cirrhosis Market Growth Evolved From 2024 To 2025, And What’s Ahead?

Recent years have seen swift growth in the liver cirrhosis market size. The market is projected to rise from $1.86 billion in 2024 to $2.01 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. Factors such as rising liver disease prevalence, elevated alcohol intake, an aging population, growth in healthcare spending, and expanded government initiatives contributed to the growth witnessed during the historic period.

In the forthcoming years, the liver cirrhosis market is poised for swift expansion. It’s predicted to inflate to $2.74 billion in 2029, with a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this projected growth include escalating cases of hepatitis infections, burgeoning economic development, heightened urbanization, shifts in lifestyle, and a surge in medical tourism. Key trends to watch during this forecast period include progress in diagnostic tools, technological breakthroughs, collaborations and partnerships, the application of artificial intelligence, and the incorporation of holistic therapies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22040&type=smp

Which Factors and External Forces Are Driving Demand in the Liver Cirrhosis Market?

The liver cirrhosis market is projected to grow due to an increase in alcohol consumption. This refers to the uptake of alcoholic drinks, quantified by how often and how much is consumed. The reason for this upsurge is that alcohol has become an effective way for many to relieve daily stress, form social bonds at events, and elevate their relaxation moments. Alcohol is also widely advertised in media and is easily obtainable in numerous places. For patients with liver cirrhosis resulting from heavy drinking, the treatment concentrates on mitigating liver damage through stopping alcohol use, administering medications, and providing supportive care. It also warrants addressing alcohol addiction through therapy and rehabilitation. For instance, the National Drugs Library, based in Ireland, recorded in March 2023 that the average alcohol intake for people over 15 years of age in 2022 escalated to 10.2 liters of pure alcohol per capita. This amounts to a 7.6% surge from the previous year, 2021. Thus, the alcohol consumption increment fuels the liver cirrhosis market expansion.

Which Segments in the Liver Cirrhosis Offer the Most Growth?

The liver cirrhosis market covered in this report is segmented –

1) By Type: Alcoholic Cirrhosis, Atrophic Cirrhosis, Biliary Cirrhosis, Cardiac Cirrhosis, Cryptogenic Cirrhosis

2) By Treatment: Antibiotics, Immunosuppressants, Other Treatments

3) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes, Other End Users

Subsegmentss:

1) By Alcoholic Cirrhosis: Compensated Alcoholic Cirrhosis, Decompensated Alcoholic Cirrhosis, Alcoholic Steatohepatitis (ASH)-Associated Cirrhosis

2) By Atrophic Cirrhosis: Post-necrotic Atrophic Cirrhosis, Macronodular Atrophic Cirrhosis, Micronodular Atrophic Cirrhosis

3) By Biliary Cirrhosis: Primary Biliary Cirrhosis (PBC), Secondary Biliary Cirrhosis, Autoimmune Biliary Cirrhosis

4) By Cardiac Cirrhosis: Right Heart Failure-Induced Cirrhosis, Chronic Passive Congestion Cirrhosis, Ischemic Hepatitis Cirrhosis

5) By Cryptogenic Cirrhosis: Non-Alcoholic Steatohepatitis (NASH)-Associated Cirrhosis, Idiopathic Cirrhosis, Metabolic Syndrome-Associated Cirrhosis

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=22040&type=smp

What Are the Fastest-Growing Geographies in the Liver Cirrhosis Market?

North America was the largest region in the liver cirrhosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cirrhosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theLiver Cirrhosis Market’s Growth?

Major corporations that are part of the liver cirrhosis market are focusing on advancing treatment methods, which include the creation of active implantable medical devices, to enhance patient health outcomes and broaden therapeutic opportunities. These devices are electronic implants created to monitor, support, or improve organ function inside the body. For example, in December 2024, a medical device company based in Belgium, Sequana Medical NV, was granted U.S. FDA approval for its innovative alfapump system. This was the first active implantable medical device for managing recurrent or refractory ascites caused by liver cirrhosis in the U.S. This cutting-edge technology brings an automatic, on-going solution for managing fluid by moving excess abdominal fluid to the bladder, which significantly minimizes the reliance on invasive therapeutic paracentesis. The alfapump symbolizes a significant progression in enhancing patient health results and improving quality of life, with a potential market of about 70,000 patients in the U.S.

View the full report here:

https://www.thebusinessresearchcompany.com/report/liver-cirrhosis-global-market-report

What Are the Key Elements That Define the Liver Cirrhosis Market?

Liver cirrhosis is a progressive disease in which healthy liver tissue is gradually replaced by scar tissue, impairing the liver’s ability to function properly. This condition results from prolonged liver damage caused by factors such as chronic alcohol consumption, viral hepatitis, or fatty liver disease.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22040

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of the Liver Cirrhosis Market?

The liver cirrhosis market is forecasted to flourish due to the rising consumption of alcohol. Alcohol consumption entails the quantity and regularity of alcoholic beverage intake. The surge in alcohol consumption can be attributed to its stress-alleviating effects, its role in bolstering social interactions at gatherings, its ability to heighten relaxation moments, and the continuous promotion and increased accessibility of it in various environments. Treatment for liver cirrhosis in individuals who heavily consume alcohol centers around managing liver damage through sobriety, medications, and supportive care, along with dealing with alcohol dependence through counseling and rehabilitation. For instance, the National Drugs Library, a data collection institution based in Ireland, reported in March 2023 that the per capita average alcohol consumption for people aged 15 years and above in 2022 stood at 10.2 liters of pure alcohol. This figure represented a 7.6% increase compared to the previous year. Hence, the upswing in alcohol consumption is fueling the growth of the liver cirrhosis market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22040&type=smp

#What is the Growth Potential of the Liver Cirrhosis Market, and How Will It Perform by 2034?

The market for liver cirrhosis has seen a swift expansion in recent years. The market, which is set to rise from $1.86 billion in 2024 to $2.01 billion in 2025, is expected to experience a compound annual growth rate (CAGR) of 8.3%. Various factors have led to the surge during the historic period which includes a rise in liver disease cases, excessive alcohol intake, an aging demographic, growing healthcare costs, and augmented initiatives from the government.

The market size for liver cirrhosis is projected to experience swift expansion in the upcoming years, crescendoing to $2.74 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 8.0%. The spike in growth during this forecast period can be linked to an increase in hepatitis infections, booming economic progress, heightened urbanization, modifications in lifestyle, and the rise of medical tourism. The forecast period is also likely to witness significant trends such as improved diagnostic tools, technological advancements, strategic collaborations and partnerships, the application of artificial intelligence, and the incorporation of all-inclusive therapies.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22040

Which Cutting-Edge Market Trends Are Expected to Drive the Liver Cirrhosis Market’s Growth?

Prominent players in the liver cirrhosis market are concentrating on innovative treatment approaches, such as the creation of active implantable medical devices, to enhance patient results and broaden treatment options. Active implantable medical devices are electronically powered implants configured to aid, monitor, or enhance the functioning of organs in the human body. For instance, in December 2024, the U.S. Food and Drug Administration approved the alfapump system of Sequana Medical NV, a medical device firm based in Belgium. This was the first active implantable medical device in the U.S for recurrent or refractory ascites management due to liver cirrhosis. This groundbreaking technology provides an automated, constant solution for fluid management by moving excess abdominal fluid to the bladder, significantly cutting down the reliance on invasive therapeutic paracentesis. Alfapump is a significant step forward in improving patient results and boosting quality of life, with a target market of roughly 70,000 patients in the United States.

What Are the Leading Market Players Impacting theLiver Cirrhosis Market’s Growth Trend?

Major companies operating in the liver cirrhosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Viatris Inc., Grifols Therapeutics LLC, Shionogi Inc., Galectin Therapeutics Inc., NGM Biopharmaceuticals Inc., Madrigal Pharmaceuticals Inc., Akero Therapeutics Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/liver-cirrhosis-global-market-report

How Are the Key Segments of the Liver Cirrhosis Market Driving Opportunities and Innovations?

The liver cirrhosis market covered in this report is segmented –

1) By Type: Alcoholic Cirrhosis, Atrophic Cirrhosis, Biliary Cirrhosis, Cardiac Cirrhosis, Cryptogenic Cirrhosis

2) By Treatment: Antibiotics, Immunosuppressants, Other Treatments

3) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes, Other End Users

Subsegmentss:

1) By Alcoholic Cirrhosis: Compensated Alcoholic Cirrhosis, Decompensated Alcoholic Cirrhosis, Alcoholic Steatohepatitis (ASH)-Associated Cirrhosis

2) By Atrophic Cirrhosis: Post-necrotic Atrophic Cirrhosis, Macronodular Atrophic Cirrhosis, Micronodular Atrophic Cirrhosis

3) By Biliary Cirrhosis: Primary Biliary Cirrhosis (PBC), Secondary Biliary Cirrhosis, Autoimmune Biliary Cirrhosis

4) By Cardiac Cirrhosis: Right Heart Failure-Induced Cirrhosis, Chronic Passive Congestion Cirrhosis, Ischemic Hepatitis Cirrhosis

5) By Cryptogenic Cirrhosis: Non-Alcoholic Steatohepatitis (NASH)-Associated Cirrhosis, Idiopathic Cirrhosis, Metabolic Syndrome-Associated Cirrhosis

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=22040&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theLiver Cirrhosis Market?# Market Expansion?

North America was the largest region in the liver cirrhosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cirrhosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Liver Cirrhosis Market 2025, By The Business Research Company:

Liver Diseases Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Liver Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Human Liver Model Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: